News
PARTNERS Trial Begins Patient Enrolment for Bundibugyo Ebola Treatments
The WHO-sponsored study in the Democratic Republic of the Congo will evaluate monoclonal antibody MBP134 and remdesivir as potential therapies for Bundibugyo virus disease.

